Laszlo Vass
Overview
Explore the profile of Laszlo Vass including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
129
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kholova I, Schmitt F, Bongiovanni M, Vass L, Vrdoljak Mozetic D
Acta Cytol
. 2024 Oct;
67(3):213-216.
PMID: 39397608
No abstract available.
2.
Kovacs G, Hella Z, Vass L, Csapo Z
Orv Hetil
. 2022 Jul;
163(27):1074-1081.
PMID: 35895468
Introduction: According to the recommendation of the American Thyroid Association 2015 guideline, the treatment of 1-4 cm (T1b-2) low-risk differentiated thyroid cancer (DTC) is lobectomy without radioiodine therapy. Objective: Retrospective...
3.
Cserni G, Francz M, Jaray B, Kalman E, Kovacs I, Krenacs T, et al.
Pathol Oncol Res
. 2022 Jul;
28:1610373.
PMID: 35845921
This text is based on the recommendations accepted by the 4th Hungarian Consensus Conference on Breast Cancer, modified on the basis of the international consultation and conference within the frames...
4.
Cserni G, Francz M, Jaray B, Kalman E, Kovacs I, Krenacs T, et al.
Magy Onkol
. 2020 Dec;
64(4):301-328.
PMID: 33313608
There have been some relevant changes in the diagnosis and treatment of breast cancer to implement the updating of the 2016 recommendations made during the 3rd national consensus conference on...
5.
Timar J, Mehes G, Vass L
Magy Onkol
. 2020 Sep;
64(3):183-189.
PMID: 32966348
Molecular classification of lung cancer developed in the past decades to the level where even the rare genetic alterations are included. Unfortunately, adenocarcinoma benefited from this development almost exclusively. Furthermore,...
6.
Cserni G, Kulka J, Francz M, Jaray B, Kalman E, Kovacs I, et al.
Magy Onkol
. 2016 Sep;
60(3):209-28.
PMID: 27579721
There have been relevant changes in the diagnosis and treatment of breast cancer to implement the updating of the 2010 recommendations made during the 2nd national consensus conference on the...
7.
Kiss O, Tokes A, Vranic S, Gatalica Z, Vass L, Udvarhelyi N, et al.
Virchows Arch
. 2015 Aug;
467(5):551-62.
PMID: 26293217
Despite their similar histomorphologic appearance, adenoid cystic carcinomas of the breast and salivary glands (bACCs and sACCs, respectively) are clinically and pathologically diverse. We studied the expression levels of 18...
8.
Cserni G, Francz M, Kalman E, Kelemen G, Komjathy D, Kovacs I, et al.
Pathol Oncol Res
. 2011 Jan;
17(3):663-8.
PMID: 21267685
Estrogen receptor (ER) testing has become an important part of breast cancer reporting as the ER status is a predictor of hormonal treatment efficacy. Progesteron receptors (PR) are often tested...
9.
Cserni G, Francz M, Jaray B, Kalman E, Kovacs I, Kulka J, et al.
Magy Onkol
. 2010 Sep;
54(3):217-26.
PMID: 20870599
No abstract available.
10.
Anttila A, von Karsa L, Aasmaa A, Fender M, Patnick J, Rebolj M, et al.
Eur J Cancer
. 2009 Aug;
45(15):2649-58.
PMID: 19699081
The aim of the study was to compare current policy, organisation and coverage of cervical cancer screening programmes in the European Union (EU) member states with European and other international...